Two type 1 diabetes patients are insulin-free after Eledon’s immunosuppressant and an islet transplant

Ele­don Phar­ma­ceu­ti­cals’ ex­per­i­men­tal im­muno­sup­pres­sant helped two pa­tients with type 1 di­a­betes go in­sulin-free fol­low­ing an islet cell trans­plant, the com­pa­ny an­nounced Tues­day.

The com­pa­ny’s stock …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.